Osteoporosis Screening in Older Women assesses the percentage of women 65–75 years of age who receive osteoporosis screening.
Why it Matters
Osteoporosis, a common metabolic bone disease, is characterized by weakening of bone tissue and bone structure, and it can increase a person’s risk for hip, spine or wrist fracture.1 Osteoporotic fractures, particularly hip fractures, are associated with chronic pain and disability, loss of independence, decreased quality of life and increased mortality.2 With appropriate screening and treatment, the risk of future osteoporosis-related fractures can be reduced.
Osteoporosis is most common in postmenopausal women, but can occur in women of any age and in men. Although individuals may not know they have osteoporosis until they break a bone, recognition of the risk factors for osteoporosis—including sex, race, age, family history, other medical conditions and use of certain medications—could lead to earlier diagnosis and treatment.
Results – National Averages
Osteoporosis Screening in Older Women
| Year | Medicare HMO | Medicare PPO |
|---|---|---|
| 2022 | 49 | 51 |
| 2021 | 46.3 | 50.6 |
This State of Healthcare Quality Report classifies health plans differently than NCQA’s Quality Compass. HMO corresponds to All LOBs (excluding PPO and EPO) within Quality Compass. PPO corresponds to PPO and EPO within Quality Compass.
Figures do not account for changes in the underlying measure that could break trending. Contact Information Products via my.ncqa.org for analysis that accounts for trend breaks.
References
- National Institutes of Health. Osteoporosis and Related Bone Diseases National Resource Center (NIH NIAMS). October 2019. “Osteoporosis: Overview.”
- S. Preventive Services Task Force. 2018. Final Recommendation Statement: Osteoporosis to Prevent Fractures: Screening.